Viridian Therapeutics Inc. (0K1R)
Market Closed
16 Oct, 03:30 PM
LSE 
$
19. 26
-0.41
-2.0834%
$
- Market Cap
- P/E Ratio
- Div Yield
153 Volume
-4.96 Eps
$ 19.67
Previous Close Want to track 0K1R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Viridian Therapeutics Inc. (0K1R) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.23B
Trailing P/E (ttm) -5.39
Forward P/E -
PEG ratio -0.6
Price/Sales (ttm) 30.31
Price/Book (mrq) 3.1
Enterprise Value/Revenue 31.41
Enterprise Value/EBITDA -6.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 551
Average volume (90 days) 1.57K
Price summary
52-Week low 13.25
52-Week high 34.31
Beta -
50-Day moving average 20.81
200-Day moving average 18.76
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 21 Sep 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -5.44%
Operating margin -5.7%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.61%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.66
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.1
Total debt (mrq) -
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 16.95%
Book value per share (mrq) 6.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
